NPHC
NUTRA PHARMA CORPCompany Information
- Company Name
- NUTRA PHARMA CORP
- CIK
- CIK0001119643
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- NPHC: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2833
- SIC Description
- Medicinal Chemicals & Botanical Products
- Ticker
- NPHC
SEC filing data through
Insider Sentiment
- Last purchase
- 2021-11-15
- Last sale
- —
- Shares purchased (TTM)
- 12,000,000
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2025-12-31
- Institutional shares owned
- 500
- Shares outstanding
- 7,778,855,639
- Ownership
- 0.00%
Earnings Market Reaction
- Filing date
- 2026-08-19
- Price on filing date
- —
- 1-month reaction
- 0.00%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Accounts Receivable Net Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Cash | - | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Receivables Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | ||||||
| Short Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Inventory Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Security Deposit | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Accrued Liabilities Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Accrued Salaries Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | ||||||
| Contract With Customer Liability Current | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Interest Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Liabilities Current | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Derivative Liabilities Current | 2 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Other Long Term Debt Current | - | - | 10 | 10 | 9 | 9 | 8 | 8 | 8 | 8 | 8 | 8 | ||||||
| Notes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Current | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 22 | 18 | 17 | 17 | 17 | 17 | 15 | 15 | 15 | 15 | 14 | 14 | ||||||
| Secured Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Long Term Notes Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 22 | 18 | 17 | 17 | 17 | 17 | 15 | 15 | 15 | 15 | 14 | 14 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | ||||||
| Additional Paid In Capital Common Stock | 54 | 54 | 54 | 54 | 54 | 54 | 54 | 54 | 54 | 54 | 54 | 54 | ||||||
| Retained Earnings Accumulated Deficit | -83 | -79 | -78 | -78 | -77 | -78 | -76 | -76 | -76 | -75 | -75 | -75 | ||||||
| Stockholders Equity | -21 | -17 | -17 | -16 | -16 | -16 | -15 | -15 | -15 | -14 | -14 | -14 | ||||||
| Liabilities And Stockholders Equity | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 12,000 | 12,000 | 12,000 | 12,000 | 12,000 | 12,000 | 12,000 | 12,000 | 12,000 | 12,000 | 12,000 | 12,000 | ||||||
| Common Stock Shares Issued | 7,160 | 7,160 | 7,100 | 7,100 | 7,100 | 7,100 | 7,100 | 7,100 | 7,100 | 7,065 | 7,065 | 7,065 | ||||||
| Shares Outstanding | 7,160 | 7,160 | 7,100 | 7,100 | 7,100 | 7,100 | 7,100 | 7,100 | 7,100 | 7,065 | 7,065 | 7,065 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialNUTRA PHARMA CORP (NPHC) — SEC Financial Statements & Analysis
NUTRA PHARMA CORP (NPHC) is a medicinal chemicals & botanical products company, incorporated in CA. NUTRA PHARMA CORP trades on OTC as: NPHC. NUTRA PHARMA CORP (NPHC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-19. Based on that filing, NUTRA PHARMA CORP carries a market cap of $1.61M, a P/E ratio of -0.30x, a P/B ratio of -0.08x, a P/S ratio of 10.03x, an enterprise value of $1.76M, and an EV/EBITDA multiple of -1.08x. On profitability, it posts a gross margin of 78.15%, an operating margin of -1017.76%, a net margin of -3370.64%, a Return on Equity (ROE) of 29.27%, and a Return on Assets (ROA) of -731.54%. Per share, it reports EPS of $-0.00, diluted EPS of $-0.00, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -49.01% year-over-year, net income growth of 254.99% year-over-year, and EPS growth of 240.74% year-over-year. On the balance sheet, it maintains a current ratio of 0.02x, a quick ratio of 0.02x, working capital of $-21.23M, a debt-to-equity ratio of -1.03x, a debt ratio of 35.05, an interest coverage ratio of -3.88x, free cash flow of $-1.05M (TTM), and net debt of $149.17K. Figures sourced from SEC EDGAR.
- Market Cap
- $1.61M
- P/E TTM
- -0.30x
- EPS TTM
- $-0.00
- P/B TTM
- -0.08x
- ROE TTM
- 29.27%
- ROA TTM
- -731.54%
- Debt To Equity
- -1.03x
- Free Cash Flow TTM
- $-1.05M
- Net Revenue TTM Growth 1Y
- -49.01%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is NUTRA PHARMA CORP in?
NUTRA PHARMA CORP (NPHC) operates in the Medicinal Chemicals & Botanical Products industry.
What exchange does NPHC trade on?
NUTRA PHARMA CORP (NPHC) trades on the OTC.
Where is NUTRA PHARMA CORP incorporated?
NUTRA PHARMA CORP is incorporated in CA.
When was NUTRA PHARMA CORP (NPHC)'s most recent SEC filing?
NUTRA PHARMA CORP (NPHC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-19.
What is NPHC's market cap?
NUTRA PHARMA CORP (NPHC) has a market capitalization of $1.61M as of 2026-06-30.
What is NPHC's EPS (earnings per share)?
NUTRA PHARMA CORP (NPHC)'s trailing twelve month EPS is $-0.00 as of 2026-06-30.
What is NPHC's ROE (return on equity)?
NUTRA PHARMA CORP (NPHC)'s trailing twelve month Return on Equity (ROE) is 29.27% as of 2026-06-30.
What is NPHC's ROA (return on assets)?
NUTRA PHARMA CORP (NPHC)'s trailing twelve month Return on Assets (ROA) is -731.54% as of 2026-06-30.
What is NPHC's EV/EBITDA?
NUTRA PHARMA CORP (NPHC)'s trailing twelve month EV/EBITDA is -1.08x as of 2026-06-30.